Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Cereb Cortex ; 20(6): 1462-75, 2010 Jun.
Article in English | MEDLINE | ID: mdl-19812240

ABSTRACT

Hypothyroxinemia affects 35-50% of neonates born prematurely (12% of births) and increases their risk of suffering neurodevelopmental alterations. We have developed an animal model to study the role of maternal thyroid hormones (THs) at the end of gestation on offspring's cerebral maturation. Pregnant rats were surgically thyroidectomized at embryonic day (E) 16 and infused with calcitonin and parathormone (late maternal hypothyroidism [LMH] rats). After birth, pups were nursed by normal rats. Pups born to LMH dams, thyroxine treated from E17 to postnatal day (P) 0, were also studied. In developing LMH pups, the cortical lamination was abnormal. At P40, heterotopic neurons were found in the subcortical white matter and in the hippocampal stratum oriens and alveus. The Zn-positive area of the stratum oriens of hippocampal CA3 was decreased by 41.5% showing altered mossy fibers' organization. LMH pups showed delayed learning in parallel to decreased phosphorylated cAMP response element-binding protein (pCREB) and phosphorylated extracellular signal-regulated kinase 1/2 (pERK1/2) expression in the hippocampus. Thyroxine treatment of LMH dams reverted abnormalities. In conclusion, maternal THs are still essential for normal offspring's neurodevelopment even after onset of fetal thyroid function. Our data suggest that thyroxine treatment of premature neonates should be attempted to compensate for the interruption of the maternal supply.


Subject(s)
Brain/abnormalities , Brain/growth & development , Infant, Premature/growth & development , Maternal-Fetal Exchange/physiology , Neurogenesis/physiology , Thyroxine/deficiency , Animals , Animals, Newborn , Body Patterning/physiology , Brain/metabolism , Developmental Disabilities/etiology , Developmental Disabilities/pathology , Developmental Disabilities/physiopathology , Disease Models, Animal , Down-Regulation/physiology , Female , Hippocampus/abnormalities , Hippocampus/growth & development , Hippocampus/metabolism , Humans , Infant, Newborn , Mossy Fibers, Hippocampal/abnormalities , Mossy Fibers, Hippocampal/metabolism , Mossy Fibers, Hippocampal/pathology , Pregnancy , Rats , Rats, Wistar , Thyroxine/metabolism , Thyroxine/therapeutic use
2.
J Endocrinol ; 187(2): 257-66, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16293773

ABSTRACT

Thyroid hormones circulate in blood mainly bound to plasma proteins. Transthyretin is the major thyroxine plasma carrier in mice. Studies in transthyretin-null mice revealed that the absence of transthyretin results in euthyroid hypothyroxinemia and normal thyroid hormone tissue distribution, with the exception of the choroid plexus in the brain. Therefore, transthyretin does not influence normal thyroid hormone homeostasis under standard laboratory conditions. To investigate if transthyretin has a buffer/storage role we challenged transthyretin-null and wild-type mice with conditions of increased hormone demand: (i) exposure to cold, which elicits thermogenesis, a process that requires thyroid hormones; and (ii) thyroidectomy, which abolishes thyroid hormone synthesis and secretion and induces severe hypothyroidism. Transthyretin-null mice responded as the wild-type both to changes induced by stressful events, namely in body weight, food intake and thyroid hormone tissue content, and in the mRNA levels of genes whose expression is altered in such conditions. These results clearly exclude a role for transthyretin in thyroid hormone homeostasis even under conditions of increased hormone demand.


Subject(s)
Cold Temperature/adverse effects , Prealbumin/metabolism , Thyroid Gland/metabolism , Thyroid Hormones/metabolism , Animals , Homeostasis , Mice , Mice, Knockout , Prealbumin/genetics , Radioimmunoassay/methods , Reverse Transcriptase Polymerase Chain Reaction , Thyroidectomy , Thyrotropin/blood , Thyroxine/blood , Triiodothyronine/blood
3.
Arch Dis Child Fetal Neonatal Ed ; 88(1): F56-7, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12496228

ABSTRACT

Infants are in negative iodine balance on current standard regimens of total parenteral nutrition, with a mean iodine intake of 3 micro g/kg/day (150 ml/kg/day). The recommended enteral intake of iodine for preterm infants is 30 micro g/kg/day. Gastrointestinal absorption of iodine is high, suggesting that parenteral intakes should approach enteral recommendations.


Subject(s)
Infant, Newborn/metabolism , Infant, Premature, Diseases/metabolism , Iodine/deficiency , Parenteral Nutrition/adverse effects , Age Factors , Digestive System/metabolism , Female , Humans , Intestinal Absorption/physiology , Iodine/pharmacokinetics , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...